Tag: CBT > medical cannabis research

Oklahoma

2026 Oklahoma Statewide Medical Marijuana Citizen Science Research Study Launches

The first-of-its-kind study will focus on health outcomes, access and patient perspectives.

April 1, 2026

Medical Cannabis Access and Pricing

Medical Cannabis at Inflection Point: Policy, Science, What Comes Next (Opinion)

From New York’s clinical leadership to emerging product standards, patient care is becoming the market’s north star.

February 10, 2026

New York

NY’s Medical Cannabis Program Reduces Opioid Use

Researchers published a study indicating that medical cannabis can relieve chronic pain and reduce patients’ reliance on prescription opioids.

December 8, 2025

Industry Headlines

Tilray Medical Publishes Pioneering Research on Pharmacokinetics of THC, CBD Formulations

The new study provides insight into the bioavailability of medical cannabis formulations for therapeutic treatment.

June 26, 2025

Columns

Innovating for the Benefit of Patients in Medical Cannabis (Opinion)

Poor bioavailability formulations in orally delivered medical cannabis have left an innovation gap for patients.

April 28, 2025

Legislation and Regulation

DOJ Will No Longer Defend Administrative Law Judges From Removal

The announcement could bolster MMJ International Holdings’ ongoing lawsuit against the DEA over a medical cannabis research application.

February 25, 2025

Cannabis Industry Research

The Man Behind DEA’s Federal Marijuana Scam

DEA Senior Policy Adviser Matthew Strait defied presidential mandates for medical research, MMJ International Holdings claims.

January 28, 2025

Industry Headlines

Does Medical Cannabis Have Physical, Mental Health Risks? Rutgers Health Kicks Off Study

Rutgers Health researchers will emphasize cannabis use disorder, which involves tolerance and dependence, in the five-year, federally funded study.

December 17, 2024

Industry Headlines

DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder

MMJ submitted an FDA Investigational New Drug application for a cannabis-derived medication.

December 11, 2024

Industry Headlines

FDA Clears MAPS Researchers to Proceed With Cannabis Study for Veterans With PTSD

The Multidisciplinary Association for Psychedelic Studies (MAPS) researchers negotiated with the FDA for three years.

November 22, 2024

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

International

Tilray Medical Launches Redecan Cannabis Brand in Australia

The company’s EU-GMP-certified medical cannabis products are now available in Australia with a prescription.

September 18, 2024